SCHEMBL8286144

SCHEMBL8286144

Cc1cc2c(c(OCCN3CCCC3)n1)c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 10/20 0.40
MCHR1 Q99705 2/20 0.40
KCNH2 Q12809 6/20 0.39
ADRA1A P35348 2/20 0.39
PDE11A Q9HCR9 1/20 0.39
YES1 P07947 1/20 0.38
SRC P12931 1/20 0.38
KDR P35968 1/20 0.38
EPHB4 P54760 1/20 0.38
HTR2A P28223 1/20 0.37
HTR2C P28335 1/20 0.37
HTR2B P41595 1/20 0.37
HRH2 P25021 1/20 0.37
JAK2 O60674 1/20 0.36
JAK3 P52333 1/20 0.36
PTK2 Q05397 1/20 0.36
BCHE P06276 1/20 0.36
ACHE P22303 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8286086 0.92 PDE11A (0.46) PDE11ASRCHTR2B
SCHEMBL8286140 0.86 PDE11A (0.37) PDE11A
SCHEMBL8286426 0.85 PDE11A (0.39) PDE11A
SCHEMBL8286078 0.84 HTR6 (0.41) PDE11ASRCKDR
SCHEMBL8286413 0.84 PDE11A (0.44) HRH3MCHR1KCNH2ADRA1APDE11A
SCHEMBL8286083 0.82 PDE11A (0.38) HRH3PDE11A
SCHEMBL8286457 0.82 LMNA (0.38) PDE11A
SCHEMBL8286424 0.81 MAT2A (0.41) PDE11A
SCHEMBL5872270 0.81 PDE11A (0.44) PDE11A
SCHEMBL8286076 0.81 PDE11A (0.39) PDE11A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed